Navigation Links
Anavex strengthens Board of Directors
Date:12/17/2007

GENEVA, Switzerland, Dec. 17 /PRNewswire-FirstCall/ - Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) today announced the appointment of Dr. Cameron Durrant to its Board of Directors. Dr. Durrant is currently Worldwide Vice President of Virology Global Strategic Marketing at Johnson & Johnson (NYSE: JNJ).

"ANAVEX is both pleased and privileged to welcome Dr. Durrant to our Board," said Dr. Kontzalis, Chief Executive Officer for ANAVEX. "Dr. Durrant is a medically trained MBA who has a unique entrepreneurial background coupled with major international pharmaceutical experience. This combination of biotech and business development credentials adds considerable depth to the ANAVEX Board and we are confident that Dr. Durrant will help guide us as we work to aggressively execute our business plan."

"This is an exciting time for ANAVEX and I welcome the opportunity to contribute to the company's continued growth," said Dr. Durrant. "ANAVEX's novel SIGMACEPTOR technology platform offers great potential for both central nervous system and cancer applications."

Before joining Johnson & Johnson, Dr. Durrant was President and CEO of Pediamed Pharmaceuticals. Dr. Durrant's background also includes executive-level positions with Merck & Co., GlaxoSmithKline and Pharmacia (now Pfizer). He was a regional winner and national finalist for Ernst & Young's Entrepreneur of the Year award in 2005. Dr. Durrant holds a MBA from Henley Management College at Oxford and a MB and BCh (equivalent to American MD degree) from the Welsh National School of Medicine in Cardiff, U.K.

About ANAVEX

Anavex Life Sciences Corp. (http://www.anavex.com) is an emergin
'/>"/>

SOURCE Anavex Life Sciences Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anavex advances drug candidate for treatment of Alzheimers disease
2. Medpace Strengthens Presence in Central Europe
3. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
4. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
5. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
6. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. KGI Elects Three New Members to Board of Trustees
9. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
10. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
11. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... October 25, 2014 Berkshire Corporation, ... pleased to announce the release of the ValuSeal® ... level of contamination containment in critical processing applications. ... and higher cleanroom environments, ValuSeal® IonX™ is a ... laundered wiper that continues Berkshire’s innovative focus on ...
(Date:10/25/2014)...  RegeneRx Biopharmaceuticals, Inc. (OTCBB: RGRX) ("the Company" or ... International Symposium on Thymosins in Health and Disease in ... "When thymosin beta 4 (TB4) linked with rhodamine (a ... in a rodent model of stroke, it was visualized ... (the functional tissue of the brain).   The leakage of ...
(Date:10/25/2014)... DUBLIN , October 24, 2014 /PRNewswire/ ... and Markets ( http://www.researchandmarkets.com/research/t5t5pd/the_global_market ) has announced the ... Carbon Nanotubes, Graphene And Other 2-D Nanomaterials ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,CNTs and graphene ... fibres known to man, with a performance-per-weight ...
(Date:10/22/2014)... , Oct. 22, 2014  Actavis plc (NYSE: ... company, and Rhythm, a biopharmaceutical company, today announced that ... Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., which is ... treatment of diabetic gastroparesis and other GI functional disorders. ... 2 trial of relamorelin for the treatment of diabetic ...
Breaking Biology Technology:Ions Are Bygones, Berkshire Announces the Release of New Innovative Cleanroom Wipers 2Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model 2The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 2The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 3The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5
... Mich., April 25 The Fraunhofer Center ... the BU,Center for Nanoscience and Nanobiotechnology hosted ... for a tour of their world class,facilities ... The intensive tour included demonstrations of ...
... April 25 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia,International, Inc. ... "the,Company"), a leading provider in the nutraceutical ... of organic nutritional food,products, supplements, and personal ... ("PRC"), today announced that it has formally ...
... BASINGSTOKE, England and PHILADELPHIA, April 25 /PRNewswire-FirstCall/,-- Shire plc (LSE: ... the three months to March,31, 2008., Q1 2008 ... - New product sales(1) $216m, 34% of product sales ... - US GAAP Operating income up 15% to $163m ...
Cached Biology Technology:Fraunhofer and Boston University Hosted Prestigious SME Tour 2China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network 2China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network 3Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 2Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 3Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 4Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 5Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 6Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 7Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 8Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 9Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 10Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 11Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 12Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 13Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 14Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 15Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 16Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 17Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 18Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 19Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 20Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 21Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 22Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 23Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 24Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 25Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 26Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 27Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 28Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 29Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 30Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 31Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 32Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 33
(Date:10/17/2014)... knowledge regarding Ebola is critical and pertinent for practicing ... global outbreak and epidemic. The Journal, Disaster Medicine ... issue, Ebola Virus and Public Health, to surround the ... this critical societal moment. , On October 17, ... Clinicians . The primer was prepared by Dr. Eric ...
(Date:10/17/2014)... German . ... When treating overdoses, doctors are often limited to supportive therapy ... is a combination of drugs involved. So what can be ... grandmother,s pills? ETH professor Jean-Christophe Leroux from the Institute of ... to this question. "The task was to develop an agent ...
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2
... Polycyclic Aromatic Compounds (PACs) on terrestrial and benthic invertebrates ... sediment contamination. Effects are assessed exposing the organisms to ... cases this results in highly predictable effects on development ... that the effects of prolonged exposure can be very ...
... researchers under the leadership of Vici-winner Merel Kindt has ... in human volunteers by administering the beta-blocker propranolol. Interestingly, ... of time. Top journal Nature Neuroscience published ... recently, it was assumed that the fear memory could ...
... well crickets adapt to rising temperatures may provide clues ... UCF scientist Wade Winterhalter landed an $860,000 grant ... study that fuses global warming models with a biological ... ground cricket, also known as the Allonemobius socius. ...
Cached Biology News:Soil and sediment contamination assessment more accurate 2An end to fear 2Crickets may predict human survivability during global warming 2
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100*...
Recombinant Feline IL-5...
... Checker Kits provide two highly efficient methods ... time-consuming plasmid preparation. By using the large-scale ... need to do is to transfer partial ... the transformation plates into the solutions provided ...
Recombinant Equine IL-4, CF...
Biology Products: